Ann: Imugene Corporate Presentation, page-212

Can you please inform us as to what you are expecting to be announced within the next 6-12months that you feel had a 95% success rate?

Are you talking about the sale of Hervax? Next results are due Q1 2024 and if those results are not amazing... well I don't think anyone will want it. As for CF33 aren't they all early phase 1 so another 2years for those results to mature leading into a phase 2? Also didn't Dr Fong indicate for early FDA approvals they would need to be specific individual targeted trails? Correct me if I'm wrong, but aren't we doing trails for all varieties of solid tumours not specific types?

I'm trying to wrap my mind around what the next milestones to look forward to that will lift our SP and save face come the AGM.